A simple cell-based assay reveals that diverse neuropsychiatric risk genes converge on primary cilia.
Human genetic studies are beginning to identify a large number of genes linked to neuropsychiatric disorders. It is increasingly evident that different genes contribute to risk for similar syndromes and, conversely, the same genes or even the same alleles cross over traditional diagnostic categories. A current challenge is to understand the cellular biology of identified risk genes. However, most genes associated with complex neuropsychiatric phenotypes are not related through a known biochemical pathway, and many have an entirely unknown cellular function. One possibility is that diverse disease-linked genes converge at a higher-level cellular structure. The synapse is already known to be one such convergence, and emerging evidence suggests the primary cilium as another. Because many genes associated with neuropsychiatric illness are expressed also outside the nervous system, as are cilia, we tested the hypothesis that such genes affect conserved features of the primary cilium. Using RNA interference to test 41 broadly expressed candidate genes associated with schizophrenia, bipolar affective disorder, autism spectrum disorder and intellectual disability, we found 20 candidates that reduce ciliation in NIH3T3 cells when knocked down, and three whose manipulation increases cilia length. Three of the candidate genes were previously implicated in cilia formation and, altogether, approximately half of the candidates tested produced a ciliary phenotype. Our results support the hypothesis that primary cilia indeed represent a conserved cellular structure at which the effects of diverse neuropsychiatric risk genes converge. More broadly, they suggest a relatively simple cell-based approach that may be useful for exploring the complex biological underpinnings of neuropsychiatric disease.
Department of Psychiatry, University of California San Francisco, San Francisco, California, United States of America.
Aaron
A
Marley
Mark
M
von Zastrow
D000818:Animals; D001714:Bipolar Disorder / Q000235:genetics; D002659:Child Development Disorders, Pervasive / Q000235:genetics; D002923:Cilia / Q000235:genetics*; D006801:Humans; D007231:Infant, Newborn; D001523:Mental Disorders / Q000235:genetics*; D051379:Mice; D008856:Microscopy, Fluorescence; D041681:NIH 3T3 Cells; D034741:RNA, Small Interfering; D012559:Schizophrenia / Q000235:genetics
D034741:RNA, Small Interfering